India will add four million more COVID-19 cases by May 1, says Giridhara Babu
The increase in daily cases has been very steep — from over 12,200 cases on March 1 to over 1,26,000
Read More
SARS-CoV-2
Health Ministry reveals the names of SEC members for COVID-19 vaccine approval
Names of members Dr. Varsha Gupta, Professor, Department of Microbiology, Government Medical College Hospital, Chandigarh; 2) Dr. Archana Thakur, Medical
Read More
What is driving COVID-19 second wave in India?
The rate of increase in cases in India during March has been faster than at any other time during the
Read More
Covaxin: SEC allows Bharat Biotech to unblind all participants above 45 years
The Subject Expert Committee has permitted Bharat Biotech to unblind all phase-3 trial participants above 45 years and offer the vaccine to those who received a placebo. The reason: vaccines (including Covaxin) are already available under the immunisation programme, and therefore all the eligible age groups should be unblinded for vaccination.
Read More
Will intranasal COVID-19 vaccines confer sterilising immunity?
Developed by Washington University School of Medicine in St. Louis, the vaccine has been licensed to Bharat Biotech to carry
Read More
Achieving COVID-19 vaccine equity by making comorbidities redundant for those above 45 years
By following the U.K. model of vaccinating people based on age bands rather than focussing on comorbidities, millions of people
Read More
Should Covaxin trial continue till 130 cases are recorded?
According to details posted on the clinical trial registry, the company had planned to “continue the phase-3 trial until 130
Read More
Will adenovirus antibodies reduce the efficacy of COVID-19 vector vaccines?
While it is unclear if pre-existing antibodies to adenovirus vector will affect vaccine efficacy, it is possible that repeated vaccination using adenovirus-based vaccine either as a booster or as annual vaccination, if the need arises, will result in reduced efficacy due to vector immunity.
Read More
As COVID-19 cases spike in a few States, what is causing a decline in Kerala?
Even as recently as March 6, March 4, March 3, March 2 and March 1 the Health Ministry mischievously implicated
Read More
Covaxin should no longer be available in ‘clinical trial mode’
The vaccine efficacy was measured based on symptomatic COVID-19 disease — mild, moderate or severe — two weeks after the
Read More
IGIB: In vaccinated people, Covishield first dose is highly immunogenic if already infected
The results have been posted on medRxiv preprint server. Preprints are yet to be peer-reviewed and published in scientific journals.
Read More
Doctors say comorbidities list for COVID-19 vaccination is highly restrictive
“The list of comorbidities provided by the Health Ministry is overly restrictive and complicated. Many conditions, including obesity, have been
Read More
Is India witnessing the beginning of the second wave?
From below 5%, the test positivity rate has suddenly shot up in Maharashtra — the seven-day average test positivity rate
Read More